BREAKING NEWS: Shares in Medlab Clinical have been suspended by the Australian Stock Exchange and its observational study abruptly halted as the market awaits an announcement of a proposed capital raise. Two non-executive directors have also left the business, while other staff have updated their LinkedIn profiles to “looking for work”.
Source: Cannabiz